Salivary Gland Infection Market Expansion Outlook: $6.04 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Salivary Gland Infection Market By 2029?

The salivary gland infection market has shown strong growth in recent years. Its value is anticipated to rise from $4.12 billion in 2024 to $4.45 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to an increase in oral health issues, heightened awareness of salivary disorders, a growing prevalence of bacterial and viral infections, expanding healthcare infrastructure, a rise in the geriatric population, and an increase in the adoption of minimally invasive treatments.

The salivary gland infection market is anticipated to experience substantial growth over the next few years. It is forecast to reach $6.04 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.9%. This expansion during the forecast period can be attributed to heightened awareness concerning oral health, the increasing embrace of minimally invasive procedures, a rising prevalence of chronic conditions, enhancements in healthcare infrastructure, and broadened patient access to specialized care. Notable trends anticipated in this period include the adoption of minimally invasive procedures, advancements in sialendoscopy techniques, sophisticated imaging technologies, the development of biocompatible stents, the integration of robotic-assisted surgeries, the implementation of targeted antimicrobial therapies, and diagnostic tools driven by artificial intelligence.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Which Industry Drivers Are Expected To Accelerate The Salivary Gland Infection Market From 2025 To 2029?

An anticipated increase in oral health problems is set to fuel the expansion of the salivary gland infections market in the future. These issues encompass conditions like dental caries, periodontal diseases, and various other mouth-related problems. The surge in oral health concerns is largely propelled by insufficient oral hygiene practices, detrimental dietary patterns, and limited access to dental services. An escalation in such challenges elevates the likelihood of salivary gland infections by fostering bacterial proliferation and obstructions within the salivary ducts. As an illustration, data from May 2024, reported by the National Health Service (NHS), a government body in the UK, indicated that 32.5 million dental treatments were administered in 2022-23, marking a 23.2% rise from the prior year. Consequently, the growing prevalence of oral health issues is a key factor propelling the expansion of the salivary gland infections market.

How Is The Salivary Gland Infection Market Segmented?

The salivary gland infectionmarket covered in this report is segmented –

1) By Diagnosis: Plain Radiography; Sialography; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Radionuclide Scintigraphy; High-resolution Ultrasonography; Other Diagnoses

2) By Treatment: Medications; Surgery; Aspiration; Home Care; Other Treatments

3) By End User: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands; Sialography With X-ray

2) By Sialography: Conventional Sialography; Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT; Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast; MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy; SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography; Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy; Endoscopy; Salivary Flow Test

Which Ongoing Trends Are Expected To Shape The Salivary Gland Infection Market Outlook?

Leading companies in the salivary gland infections market are emphasizing technological progress, especially in minimally invasive procedures, to optimize treatment results, expedite patient healing, and boost overall healthcare efficacy. Minimally invasive methods utilize smaller cuts and specialized equipment, resulting in reduced tissue damage and promoting more rapid recovery. As an illustration, in March 2024, Amrita Hospital, an India-based healthcare institution, unveiled the Amrita Centre for minimally invasive salivary gland surgery. This center delivers a pioneering treatment for salivary disorders using sialendoscopy, which minimizes the requirement for surgery and preserves glandular function. The inauguration was distinguished by a two-day workshop that presented expert demonstrations.

Which Key Players Are Driving Competition In The Salivary Gland Infection Market?

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

What Are The Key Regional Factors Influencing The Salivary Gland Infection Market Growth?

North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Salivary Gland Infection Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21281&type=smp

Browse Through More Reports Similar to the Global Salivary Gland Infection Market 2025, By The Business Research Company

Hospital Acquired Infection Control Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

High Level Disinfection Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/high-level-disinfection-services-global-market-report

Uv Disinfection Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/uv-disinfection-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795